Antimicrobial Blue Light Inactivation of Gram-Negative Pathogens in Biofilms: In Vitro and In Vivo Studies.

Antimicrobial Blue Light Inactivation of Gram-Negative Pathogens in Biofilms: In Vitro and In Vivo Studies.
复制标题

DOI:
10.1093/infdis/jiw070
复制
发表时间:
2016-05
期刊:
The Journal of infectious diseases
影响因子:
--
通讯作者:
Yucheng Wang;Ximing Wu;Jia Chen;Rehab Amin;Min Lu;Brijesh Bhayana;Jie Zhao;C. Murray;Michael R Hamblin;D. Hooper;T. Dai
Yucheng Wang;Ximing Wu;Jia Chen;Rehab Amin;Min Lu;Brijesh Bhayana;Jie Zhao;C. Murray;Michael R Hamblin;D. Hooper;T. Dai
中科院分区:
其他
文献类型:
--
作者:
Yucheng Wang;Ximing Wu;Jia Chen;Rehab Amin;Min Lu;Brijesh Bhayana;Jie Zhao;C. Murray;Michael R Hamblin;D. Hooper;T. Dai

文献摘要

相似文献

BACKGROUND Biofilms affect >80% bacterial infections in human and are usually difficult to eradicate because of their inherent drug resistance. METHODS We investigated the effectiveness of antimicrobial blue light (aBL) (wavelength, 415 nm) for inactivating Acinetobacter baumannii or Pseudomonas aeruginosa biofilms in 96-well microplates or infected mouse burn wounds. RESULTS In vitro, in 96-well microplates, exposure of 24-hour-old and 72-hour-old A. baumannii biofilms to 432 J/cm(2) aBL resulted in inactivation of 3.59 log10 and 3.18 log10 colony-forming units (CFU), respectively. For P. aeruginosa biofilms, similar levels of inactivation-3.02 log10 and 3.12 log10 CFU, respectively-were achieved. In mouse burn wounds infected with 5 × 10(6) CFU ofA. baumannii, approximately 360 J/cm(2) and 540 J/cm(2) aBL was required to inactivate 3 log10 CFU in biofilms when delivered 24 and 48 hours, respectively, after bacterial inoculation. High-performance liquid chromatography analysis revealed the presence of endogenous porphyrins in both A. baumannii and P. aeruginosa TUNEL assay detected no apoptotic cells in aBL-irradiated mouse skin at up to 24 hours after aBL exposure (540 J/cm(2)). CONCLUSIONS aBL has antimicrobial activity in biofilms ofA. baumannii and P. aeruginosa and is a potential therapeutic approach for biofilm-related infections.